Stock IBAB ION BEAM APPLICATIONS, SA
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Ion Beam Applications, SA

Equities

IBAB

BE0003766806

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:13 2024-05-03 am EDT 		5-day change 1st Jan Change
13.74 EUR +4.89% Intraday chart for Ion Beam Applications, SA +6.84% +19.06%
May. 02 Ion Beam Applications SA Signs Contract with Yale New Haven Health and Hartford HealthCare to Install Proteus®?One Proton Therapy Solution in Connecticut, US CI
Mar. 21 Ion Beam Applications SA to Recommend Dividend for 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US
GL
Ion Beam Applications : IBA Annual Report 2023
PU
Iba – Transparency Notification
GL
IBA Reports Full Year 2023 Results
GL
IBA signs contract to install a Be-Efficient irradiation solution in Germany
GL
PanTera signs a second agreement for the supply of actinium-225
GL
IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa
GL
IBA Notice of Full Year 2023 Results and Conference Call
GL
IBA – Transparency Notification
GL
PanTera signs agreement with Bayer for the supply of actinium-225
GL
IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence
GL
IBA – Transparency Notification
GL
IBA – TRANSPARENCY NOTIFICATION
GL
IThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone® 70
GL
IBA - Regulated Information
GL
IBA – Transparency Notification
GL
IBA – Transparency Notification
GL
IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center
GL
IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron
GL
IBA, CMI and Life Molecular Imaging announce Japanese approval for the reimbursement of amyloid-PET diagnostic Neuraceq® in Alzheimer's disease
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IBAB Stock
  4. News Ion Beam Applications, SA
  5. Press Releases